BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1399364)

  • 1. Does total thyroidectomy induce metabolic bone disturbance?
    Sugino K; Kure Y; Iwasaki H; Matsumoto A
    Int Surg; 1992; 77(3):178-80. PubMed ID: 1399364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone metabolism in thyroidectomized patients--evaluation of bone mineral content by quantitative CT].
    Sugino K; Kure Y; Suzuki A; Sekino H; Iwasaki H; Goto H; Matsumoto A
    Nihon Geka Gakkai Zasshi; 1990 Apr; 91(4):500-7. PubMed ID: 2377165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-thyroidectomy osteoporosis].
    Wang Y; Wu H; Zhou J
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):308-9. PubMed ID: 9387330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of parathyroid status and Ca and vitamin-D supplementation on bone mass and muscle-bone relationships in 208 Belarussian children after thyroidectomy because of thyroid carcinoma.
    Schneider P; Biko J; Reiners C; Demidchik YE; Drozd VM; Capozza RF; Cointry GR; Ferretti JL
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):444-50. PubMed ID: 15372365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible effect of calcitonin deficiency on bone mass after subtotal thyroidectomy.
    Mirzaei S; Krotla G; Knoll P; Koriska K; Köhn H
    Acta Med Austriaca; 1999; 26(1):29-31. PubMed ID: 10230474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced bone mineral content in totally thyroidectomized patients: possible effect of calcitonin deficiency.
    McDermott MT; Kidd GS; Blue P; Ghaed V; Hofeldt FD
    J Clin Endocrinol Metab; 1983 May; 56(5):936-9. PubMed ID: 6833470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study of thyroid hormone and bone metabolism in the rat].
    Ding G
    Zhonghua Yi Xue Za Zhi; 1990 Apr; 70(4):198-200, 16. PubMed ID: 2167757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens and bone mineral content in patients with subtotal thyroidectomy for benign nodular disease.
    Lakatos P; Tarján G; Mérei J; Földes J; Holló I
    Acta Med Hung; 1989; 46(4):297-305. PubMed ID: 2636363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone tissue mineral density in patients with thyroid gland cancer on levothyroxine natrium therapy].
    Khmara IM; Tolkachev IuV
    Klin Med (Mosk); 2005; 83(10):61-5. PubMed ID: 16320850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone density and mineral metabolism in calcitonin-deficiency patients].
    Cappelli C; Cottarelli C; Cumetti D; Agosti B; Gandossi E; Rizzoni D; Agabiti Rosei E
    Minerva Endocrinol; 2004 Mar; 29(1):1-10. PubMed ID: 15258552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical complications after total thyroidectomy and resections for differentiated thyroid carcinoma.
    Sand J; Palkola K; Salmi J
    Ann Chir Gynaecol; 1996; 85(4):305-8. PubMed ID: 9014059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic considerations and operative strategy in papillary thyroid carcinoma: arguments against the routine performance of total thyroidectomy.
    Cohn KH; Bäckdahl M; Forsslund G; Auer G; Zetterberg A; Lundell G; Granberg PO; Löwhagen T; Willems JS; Cady B
    Surgery; 1984 Dec; 96(6):957-71. PubMed ID: 6505969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin activity assessed by calcium tolerance test in patients with thyroid disorders.
    Blahos J
    Endokrinologie; 1975 Jan; 64(2):191-5. PubMed ID: 1149692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
    Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
    Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total thyroidectomy: the treatment of choice in differentiated thyroid carcinoma?
    van der Sluis RF; Wobbes T
    Eur J Surg Oncol; 1985 Dec; 11(4):343-6. PubMed ID: 2998885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis.
    Camisasca M; Crosignani A; Battezzati PM; Albisetti W; Grandinetti G; Pietrogrande L; Biffi A; Zuin M; Podda M
    Hepatology; 1994 Sep; 20(3):633-7. PubMed ID: 8076921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total-body bone mineral content in non-corticosteroid-treated postpubertal females with juvenile rheumatoid arthritis: frequency of osteopenia and contributing factors.
    Henderson CJ; Specker BL; Sierra RI; Campaigne BN; Lovell DJ
    Arthritis Rheum; 2000 Mar; 43(3):531-40. PubMed ID: 10728745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone density in differentiated cancer of the thyroid gland treated by hormone-suppressive therapy. Study based on 51 cases].
    Eulry F; Bauduceau B; Lechevalier D; Magnin J; Crozes P; Flageat J; Gautier D
    Rev Rhum Mal Osteoartic; 1992 Apr; 59(4):247-52. PubMed ID: 1496271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The late effect of subtotal thyroidectomy and radioactive iodine therapy on calcitonin secretion and bone mineral density in women treated for Graves' disease.
    Lowery WD; Thomas CG; Awbrey BJ; Rosenstein BD; Talmage RV
    Surgery; 1986 Dec; 100(6):1142-9. PubMed ID: 3787472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone mass and biochemical parameters in metabolic bone diseases].
    Negoro Y; Tomita A; Masahashi T; Suzuki M; Noguchi M; Nakanishi M
    Rinsho Byori; 1991 Sep; 39(9):934-9. PubMed ID: 1942567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.